News | December 12, 2022
Entod Pharmaceuticals to launch GLO division
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
The Business Undertaking of Watson is engaged in the business of developing, manufacturing, marketing and sale of API.
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
Total investment envisaged in this project stands at up to Rs 70 crore
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
Subscribe To Our Newsletter & Stay Updated
